Flagship Pioneering 's Flagship Origination Partner Scott Lipnick shared his perspective for The Labs Report on the gap between disease detection and when it begins.
Public source
Publisher name
Public post
The gap between when disease begins and when we can detect it is closing. Flagship Origination Partner Scott Lipnick shares what happens next, in his recent perspective…
Company
Flagship Pioneering
We are a biotechnology company that invents and builds platform companies that change the world.
- Industry
- Biotechnology Research
- Location
- Cambridge, US
- Company size
- 501–1,000 employees
About Flagship Pioneering
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises over 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, and Tessera Therapeutics.
See moreLatest activity
Latest activity from Flagship Pioneering
9 signals
Products & Services
Flagship Pioneering is launching Pioneering Abundance, a new initiative built around producing resources in abundance at a sustainable scale.
Strategy & Corporate Development
Flagship Pioneering is working across an ecosystem of first-in-class assets to de-risk translational and regulatory pathways.
Presence & Recognition
Flagship Pioneering featured Jonah Cool, Avak Kahvejian, Lovisa Afzelius, Ryan Rapp, and Bram Govaerts in a LinkedIn post discussing Polyintelligence.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Flagship Biosciences, Inc.
Flagship Biosciences, Inc. published a white paper titled Manual vs Digital Image Analysis breaking down how each approach holds up on the two points that matter most in drug development: consistency and scale.
Research & Knowledge
Intrepid Labs
Intrepid Labs Senior Director of Engineering Dr. Riley Hickman published an article for Lab Manager exploring how traditional measures of productivity in exploratory R&D do not fully capture the story.
Research & Knowledge
Wyss Institute at Harvard University
Wyss Institute at Harvard University announced that this year's class of 23 Validation Projects, spanning diagnostics, therapeutics, and sustainable solutions, is poised to improve the lives of patients and the planet.
Research & Knowledge
Frontier Medicines
Frontier Medicines CEO Chris Varma discussed progress over the years in pursuing targets previously considered undruggable, combining chemoproteomics, covalent chemistry, and AI.
Research & Knowledge
Kiin Bio